Search our Database of Scientific Publications and Authors

I’m looking for a

    2461 results match your criteria Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology[Journal]

    1 OF 50

    Protective effects of methotrexate against ischemic cardiovascular disorders in patients treated for rheumatoid arthritis or psoriasis: novel therapeutic insights coming from a meta-analysis of the literature data.
    Anadolu Kardiyol Derg 2015 Feb 16. Epub 2015 Feb 16.
    Cardiology Unit, Presidio Sanitario Intermedio "Elena d'Aosta"; Napoli-Italy.
    Objective: The association between chronic use of methotrexate and decreased risk of ischemic cardiovascular events (CVE) among patients with psoriatic or rheumatoid arthritis (RA) was investigated using a systematic review and meta-analysis.

    Methods: The studies should have recruited adults receiving methotrexate, followed up for at least one year. Moreover, studies should have reported "hard" cardiovascular endpoints, by evaluating the cardiovascular outcomes of the habitual users of the drug or of new users compared with patients with the same disease who had never used methotrexate. Read More

    Valsartan after myocardial infarction.
    Anadolu Kardiyol Derg 2014 Dec;14 Suppl 2:S9-13
    Department of Cardiology, Faculty of Medicine, Ankara University; Ankara-Turkey.
    One of the important problems of the patients undergoing acute myocardial infarction (MI) is early development of heart failure. It has been revealed in various studies that renin-angiotensin-aldosterone system (RAAS) has a significant role in this process. The studies conducted with angiotensin converting enzyme (ACE) inhibitors have resulted in decreased mortality rate. Read More

    Hypertension and valsartan.
    Anadolu Kardiyol Derg 2014 Dec;14 Suppl 2:S20-4
    Department of Medical Pharmacology, İstanbul Faculty of Medicine, İstanbul University; İstanbul-Turkey.
    Hypertension, which is pointed to be the most frequent cause of death in the World and in Turkey and defined by the World Health Organization as global health crisis and the prominent risk factor for cardiovascular diseases, is a problem threatening public health. Renin-angiotensin system (RAS) plays an important role in pathophysiology and in turn treatment of the disease. The drugs suppressing RAS are recommended both for monotherapy and combinations. Read More

    Renal and metabolic effects of valsartan.
    Anadolu Kardiyol Derg 2014 Dec;14 Suppl 2:S14-9
    Department of Internal Medicine, Division of Nephrology, Faculty of Medicine, İstanbul Bilim University; İstanbul-Turkey.
    It is known that the drugs which suppress the renin-angiotensin-aldosterone system can prevent target organ damage, independent of their blood pressure lowering effects. Besides, it has been reported that this group of drugs has positive metabolic effects. There are many studies showing that valsartan, being an angiotensin receptor blocker and widely used in hypertension treatment, has cardioprotective and renoprotective effects in high risk patients. Read More

    Renin-angiotensin system blockade in the treatment of heart failure and the role of valsartan in this treatment.
    Anadolu Kardiyol Derg 2014 Dec;14 Suppl 2:S1-8
    Department of Cardiology, Cerrahpaşa Faculty of Medicine, İstanbul University; İstanbul-Turkey.
    Heart failure which occurs due to various causes including primarily coronary artery diseases and hypertension is a syndrome with complex physiopathology and clinic that can impair patients' quality of life or lead to death. However, it is well known that the activation of renin-angiotensin system (RAS) has an important role in the physiopathology of heart failure with reduced ejection fraction. Therefore, suppression of this system for achieving a gain in the treatment of the disease has been among prominent concerns. Read More

    How will 2014 European Society of Cardiology Congress influence our daily practice?
    Anadolu Kardiyol Derg 2014 Dec;14(8):669-73
    Department of Cardiology, Faculty of Medicine, Cumhuriyet University; Sivas-Turkey.
    European Cardiology Congress which was held in Barcelona in this year; was a meeting with striking results of the presented scientific studies. Herein, a brief overview of congress highlights is presented. Read More

    Noninvasive cardiac imaging for the diagnosis of coronary artery disease in women.
    Anadolu Kardiyol Derg 2014 Dec 23;14(8):741-6. Epub 2014 Jun 23.
    Cardiology Clinic, Türkiye Yüksek İhtisas Training and Research Hospital; Ankara-Turkey.
    Cardiovascular diseases are the foremost cause of morbidity and mortality for both genders worldwide. Appropriate diagnostic tests with increased accuracy and safety provide the decisive relationship between diagnosis and treatment of coronary artery disease (CAD). However, it has been known that women at risk for occurrence of CAD are less often conducted for the proper diagnostic tests compared to men. Read More

    Fixed-dose combination of losartan and hydrochlorothiazide significantly improves endothelial function in uncontrolled hypertension by low-dose amlodipine: a randomized study.
    Anadolu Kardiyol Derg 2014 Dec 23;14(8):685-91. Epub 2014 Oct 23.
    Department of Intensive Care Medicine, National Defense Medical College; Saitama-Japan.
    Objective: Flow-mediated dilation (FMD) and nitroglycerin-mediated dilation (NMD) in the brachial artery are well-known indices for evaluating endothelial function (ECF). The blood pressure-lowering effects of the combination of losartan (ARB) and low-dose hydrochlorothiazide (H: ARB-H; ARB, 50 mg and H, 12.5 mg) are useful. Read More

    1 OF 50